206 related articles for article (PubMed ID: 24380633)
1. The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.
Dhule SS; Penfornis P; He J; Harris MR; Terry T; John V; Pochampally R
Mol Pharm; 2014 Feb; 11(2):417-27. PubMed ID: 24380633
[TBL] [Abstract][Full Text] [Related]
2. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
Barui S; Saha S; Yakati V; Chaudhuri A
Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
Dhule SS; Penfornis P; Frazier T; Walker R; Feldman J; Tan G; He J; Alb A; John V; Pochampally R
Nanomedicine; 2012 May; 8(4):440-51. PubMed ID: 21839055
[TBL] [Abstract][Full Text] [Related]
4. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
Zhai L; Sun N; Han Z; Jin HC; Zhang B
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
6. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
7. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
[TBL] [Abstract][Full Text] [Related]
8. PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.
Zou P; Stern ST; Sun D
Pharm Res; 2014 Mar; 31(3):684-93. PubMed ID: 24065591
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
[TBL] [Abstract][Full Text] [Related]
10. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
Stover TC; Sharma A; Robertson GP; Kester M
Clin Cancer Res; 2005 May; 11(9):3465-74. PubMed ID: 15867249
[TBL] [Abstract][Full Text] [Related]
11. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
12. C6 ceramide sensitizes pemetrexed-induced apoptosis and cytotoxicity in osteosarcoma cells.
Zhu X; Du X; Deng X; Yi H; Cui S; Liu W; Shen A; Cui Z
Biochem Biophys Res Commun; 2014 Sep; 452(1):72-8. PubMed ID: 25152399
[TBL] [Abstract][Full Text] [Related]
13. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Lin YL; Liu YK; Tsai NM; Hsieh JH; Chen CH; Lin CM; Liao KW
Nanomedicine; 2012 Apr; 8(3):318-27. PubMed ID: 21704596
[TBL] [Abstract][Full Text] [Related]
14. C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro.
Yu T; Li J; Sun H
Cancer Chemother Pharmacol; 2010 Oct; 66(5):999-1003. PubMed ID: 20521051
[TBL] [Abstract][Full Text] [Related]
15. Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells.
Shao J; Zheng D; Jiang Z; Xu H; Hu Y; Li X; Lu X
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):267-74. PubMed ID: 21349881
[TBL] [Abstract][Full Text] [Related]
16. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
[TBL] [Abstract][Full Text] [Related]
17. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
[TBL] [Abstract][Full Text] [Related]
18. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Narayanan NK; Nargi D; Randolph C; Narayanan BA
Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres.
Chang R; Sun L; Webster TJ
Int J Nanomedicine; 2015; 10():3351-65. PubMed ID: 26005346
[TBL] [Abstract][Full Text] [Related]
20. The second-generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells.
Kelly B; Thamm D; Rosengren RJ
Vet Comp Oncol; 2023 Dec; 21(4):595-604. PubMed ID: 37435770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
